HS
RVLP

HighVista Strategies’s RVL Pharmaceuticals plc Ordinary Shares RVLP Stock Holding History

HighVista Strategies’s Portfolio RVLP Stock Details RVLP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-11,800
Closed -$79K – 136
2020
Q2 		$79K Buy
+11,800
New +$57.7K 0.07% 80

Other funds holding RVLP

DCM
DG Capital Management New York $326M AUM 39.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CCM
CAAS Capital Management New York $934M AUM 1.45% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

HighVista Strategies's RVLP Position: Q3 2020 in Review

HighVista Strategies sold out of RVL Pharmaceuticals plc Ordinary Shares (RVLP) in Q3 2020, closing a stake of 11,800 shares — an estimated $79K sold.

HighVista Strategies first reported a position in RVLP in Q2 2020 and held it in 1 quarter. The position peaked at $79K in Q2 2020. 62 funds tracked by Wall St. Rank hold RVLP as of Q3 2020.

  • HighVista Strategies reported no remaining RVL Pharmaceuticals plc Ordinary Shares position as of Q3 2020 after selling out during the quarter.
  • HighVista Strategies sold 11,800 RVL Pharmaceuticals plc Ordinary Shares shares in Q3 2020, an estimated $79K.
  • HighVista Strategies first reported a position in RVL Pharmaceuticals plc Ordinary Shares in Q2 2020 and held it in 1 quarter.
  • HighVista Strategies's RVL Pharmaceuticals plc Ordinary Shares position peaked at $79K in Q2 2020.
  • 62 funds tracked by Wall St. Rank held RVL Pharmaceuticals plc Ordinary Shares as of Q3 2020.

Based on HighVista Strategies's 13F filing for Q3 2020, filed 16 Nov 2020.